Neramexane.
D000437:Alcoholism / Q000188:drug therapy*; D000818:Animals; D003517:Cyclopentanes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D003517:Cyclopentanes; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; C114144:neramexane